Oregon Health and Science University Microarray Core Facility Licenses Metacore from Genego
News Nov 14, 2007
GeneGo, Inc. has announced that OHSU Affymetrix microarray core facility licensed a portfolio of its data analysis products. OHSU scientists will use MetaCore for pathway analysis; MetaDrug for chemogenomics, MapEditor for pathway editing and communication and MetaLink for adding their own interactions to MetaCore’s manually curated pathways.
The Affymetrix Microarray Core (AMC) facility provides RNA Expression Profiling and DNA Variation Analysis services using Affymetrix GeneChip® oligonucleotide arrays. DNA Variation services include genome wide SNP genotyping, copy number and LOH detection.
“We are very pleased to have the OHSU core microarray center as a GeneGo customer,” said Julie Bryant, Vice President of Business Development for GeneGo.
“OMICs core labs are our primary customers, as they provide both assays and analysis to the research communities at the universities. By having access to all of our tools OHSU will have a comprehensive platform for analyzing pathways, adding proprietary data through editing capabilities and easy sharing with colleagues by just right clicking on experiments or analyses.”
More and more consumers are using services like 23andMe to learn about their genetic blueprint. Included with most of these services is the ability for users to download their "raw" genetic data, which can be further analyzed using third-party apps. But little is known about how and why consumers are using these apps, or about a variety of potential risks associated with these apps, until now.READ MORE